Trazimera 150 mg

Traximera 150 mg is a powder for solution used in intravenous therapy. It contains trastuzumab, a monoclonal antibody for targeted treatment. Learn more about its uses and effects.

Traximera 150 mg is primarily used in the treatment of certain types of breast and stomach cancers. It works by targeting specific proteins on cancer cells, helping to slow or stop their growth. This medication is often used in combination with other cancer treatments. What is Traximera used for? It is typically prescribed for HER2-positive breast and stomach cancers, as determined by a healthcare provider.

Common effects of Traximera 150 mg may include fatigue, nausea, and fever. Some individuals might experience more severe reactions such as infusion-related symptoms like chills or shortness of breath. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Traximera 150 mg should be handled with care and prepared by a healthcare professional. It is crucial to follow proper storage and administration guidelines to ensure safety. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Traximera 150 mg may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also impact the effectiveness of this treatment.